Carlsmed, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Michael Cordonnier
- Full Time Employees
- 127
- Sector
- Technology services
- Industry
- Information technology services
- Address
- 1800 Aston Avenue Carlsbad CA United States 92008
- IPO Date
- Jul 23, 2025
- CIK
- 0001794546
- Website
- carlsmed.com
- Similar Companies
- Business
- <x<x
Company News
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
Carlsmed, Inc. Announces Chief Operating Officer Appointment
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform
Carlsmed, Inc. (CARL) Presents at Bank of America SMID Cap Virtual Conference Transcript
Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript
Carlsmed Q2 Earnings Call Highlights
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet
Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates